Deal Announcements

CardioDx Scores $58 Million Venture Capital Round

Tuesday, August 28, 2012 5:33:00 AM PDT | VentureDeal

   Palo Alto, California  --  Genomic diagnostic company CardioDx has received $58 million in its sixth round of venture capital investment.

CardioDx develops genomic tests to aid in diagnosing and treating patients with cardiovascular disease.

The company was backed by a large syndicate of venture capital, private equity and corporate investors.

CardioDx said it would use the proceeds to support the commercial expansion of its gene expression test.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1